Expert Rev Clin Pharmacol. 2010;13(4):563-580.

In short, women in midlife experience a lot of changes to their skin, and navigating the hyper-saturated skin care market can ...

such as acne and seborrhea (oily skin). Accordingly, the administration of a compound that lowers androgen levels and attenuates androgen action is a potential therapy of choice for hirsutism and ...

Opzelura is under clinical development by Incyte and currently in Phase II for Unspecified Dermatological Disorders.

Acne remains a very common inflammatory dermatosis, which is often associated with significant psychological morbidity. It frequently affects young adults at a time when they are undergoing ...

After hours: January 8 at 5:52:10 p.m. EST ...

Ruxolitinib phosphate (INCB-018424) is under development for the treatment of prurigo nodularis (PN), graft versus host disease, discoid lupus erythematosus, vitiligo and atopic dermatitis, hand ...